Cargando…
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB(1)R) Antagonist
[Image: see text] Seven-transmembrane receptors signal via G-protein- and β-arrestin-dependent pathways. We describe a peripheral CB(1)R antagonist (MRI-1891) highly biased toward inhibiting CB(1)R-induced β-arrestin-2 (βArr2) recruitment over G-protein activation. In obese wild-type and βArr2-knock...
Autores principales: | Liu, Ziyi, Iyer, Malliga R., Godlewski, Grzegorz, Jourdan, Tony, Liu, Jie, Coffey, Nathan J., Zawatsky, Charles N., Puhl, Henry L., Wess, Jürgen, Meister, Jaroslawna, Liow, Jeih-San, Innis, Robert B., Hassan, Sergio A., Lee, Yong Sok, Kunos, George, Cinar, Resat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204328/ https://www.ncbi.nlm.nih.gov/pubmed/34151207 http://dx.doi.org/10.1021/acsptsci.1c00048 |
Ejemplares similares
-
Cholesterol as a modulator of cannabinoid receptor CB(2) signaling
por: Yeliseev, Alexei, et al.
Publicado: (2021) -
Peripheral Hybrid CB(1)R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis
por: Zawatsky, Charles N., et al.
Publicado: (2021) -
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia
por: Santos-Molina, Luis, et al.
Publicado: (2021) -
Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
por: Zawatsky, Charles N., et al.
Publicado: (2020) -
Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity‐induced chronic kidney disease
por: Udi, Shiran, et al.
Publicado: (2019)